Peak Frameworks

SEPTEMBER 19, 2023

For example, while a pharmaceutical company focused solely on shareholder value might prioritize high-margin drugs for rare conditions, a stakeholder-oriented approach might consider affordability and broader societal health needs , as seen with Gilead's approach to its HIV medications.

Corporation 52

Corporation Private Equity Mergers and Acquisitions Corporate Finance 52

The Deal

OCTOBER 2, 2023

Nonsan, South Korea-based Routejade makes graphite-based lithium-ion batteries for consumer electronics such as wearable technology, as well as in medical, industrial military applications. production capacity after it went public through a special purpose acquisition company. So, it’s a lot of intellectual property.

Manufacturing 69

Manufacturing Electronics IT Investors 69

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

How2Exit

MARCH 7, 2023

Ron Concept 1: Know The Risks of M&A When it comes to mergers and acquisitions (M&A), it is essential to understand the risks involved. Additionally, an attorney can help to negotiate and draft the necessary documents to ensure that the deal is legally sound. Subscribe to The Hub - Acquisitions Hub

M&A 130

M&A Investors Mergers and Acquisitions IT 130

OfficeHours

JULY 18, 2023

One of these “new” strategies that has grown in popularity over the past decade is the concept of “roll-ups” (also sometimes called “platform acquisition strategies”). This begs an important question: why do roll-ups receive a higher value than smaller acquisition targets? and thus receive volume discounts with better pricing.

Private Equity 130

Private Equity Equities Investment Mergers and Acquisitions 130

Cooley M&A

JANUARY 24, 2020

Federal Trade Commission (FTC) are particularly focused on acquisitions of “nascent technologies” by incumbent high-tech platforms. Scrutiny has become increasingly intense if the primary benefit of the deal appears to stultify a budding competitive threat – the so-called “killer acquisition.”

M&A 40

M&A Mergers and Acquisitions Mergers Business 40

Cooley M&A

JANUARY 25, 2023

The year started off with a bang, with mega-deals such as Microsoft’s pending $69 billion acquisition of Activision Blizzard, Elon Musk’s $44 billion acquisition of Twitter and Broadcom’s pending $61 billion acquisition of VMware inked in quick succession. Tech M&A in 2022 was a tale of two halves.

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Cooley M&A

JANUARY 20, 2022

1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 25, 2024

billion tie-up between Inmarsat and Viasat was cleared by both regulators, Adobe’s $20 billion proposed acquisition of Figma was abandoned in December 2023 following regulatory pressure. For example, while the $7.3

M&A 52

M&A Mergers and Acquisitions Government Investment 52